rs2190242
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001883.5(CRHR2):c.230-2546G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.775 in 152,062 control chromosomes in the GnomAD database, including 46,150 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.78 ( 46150 hom., cov: 31)
Consequence
CRHR2
NM_001883.5 intron
NM_001883.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.268
Publications
35 publications found
Genes affected
CRHR2 (HGNC:2358): (corticotropin releasing hormone receptor 2) The protein encoded by this gene belongs to the G-protein coupled receptor 2 family, and the subfamily of corticotropin releasing hormone receptor. This receptor shows high affinity for corticotropin releasing hormone (CRH), and also binds CRH-related peptides such as urocortin. CRH is synthesized in the hypothalamus, and plays an important role in coordinating the endocrine, autonomic, and behavioral responses to stress and immune challenge. Studies in mice suggest that this receptor maybe involved in mediating cardiovascular homeostasis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.821 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRHR2 | NM_001883.5 | c.230-2546G>T | intron_variant | Intron 2 of 11 | ENST00000471646.6 | NP_001874.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.775 AC: 117770AN: 151944Hom.: 46107 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
117770
AN:
151944
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.775 AC: 117864AN: 152062Hom.: 46150 Cov.: 31 AF XY: 0.768 AC XY: 57110AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
117864
AN:
152062
Hom.:
Cov.:
31
AF XY:
AC XY:
57110
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
34364
AN:
41462
American (AMR)
AF:
AC:
11907
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2745
AN:
3472
East Asian (EAS)
AF:
AC:
2348
AN:
5144
South Asian (SAS)
AF:
AC:
2576
AN:
4810
European-Finnish (FIN)
AF:
AC:
8222
AN:
10572
Middle Eastern (MID)
AF:
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53118
AN:
67986
Other (OTH)
AF:
AC:
1613
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1305
2610
3915
5220
6525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1752
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.